A detailed history of Geode Capital Management, LLC transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 3,846,675 shares of IBRX stock, worth $10.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,846,675
Previous 3,917,494 1.81%
Holding current value
$10.1 Million
Previous $24.8 Million 42.36%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$3.32 - $6.7 $235,119 - $474,487
-70,819 Reduced 1.81%
3,846,675 $14.3 Million
Q2 2024

Aug 09, 2024

BUY
$4.82 - $9.15 $2.1 Million - $3.99 Million
436,108 Added 12.53%
3,917,494 $24.8 Million
Q1 2024

May 13, 2024

BUY
$3.23 - $6.17 $329,208 - $628,858
101,922 Added 3.02%
3,481,386 $18.7 Million
Q4 2023

Feb 13, 2024

BUY
$1.25 - $5.21 $716,601 - $2.99 Million
573,281 Added 20.43%
3,379,464 $17 Million
Q3 2023

Nov 13, 2023

BUY
$1.29 - $3.1 $97,692 - $234,766
75,731 Added 2.77%
2,806,183 $4.74 Million
Q2 2023

Aug 11, 2023

BUY
$1.53 - $6.41 $1.2 Million - $5.03 Million
784,588 Added 40.32%
2,730,452 $7.59 Million
Q1 2023

May 15, 2023

SELL
$1.35 - $4.78 $114,247 - $404,521
-84,628 Reduced 4.17%
1,945,864 $3.54 Million
Q4 2022

Feb 13, 2023

BUY
$4.35 - $6.77 $473,728 - $737,273
108,903 Added 5.67%
2,030,492 $10.3 Million
Q3 2022

Nov 14, 2022

BUY
$3.65 - $6.43 $1.27 Million - $2.24 Million
348,755 Added 22.17%
1,921,589 $9.55 Million
Q2 2022

Aug 12, 2022

BUY
$2.68 - $6.14 $66,514 - $152,388
24,819 Added 1.6%
1,572,834 $5.85 Million
Q1 2022

May 13, 2022

SELL
$5.05 - $7.53 $43,359 - $64,652
-8,586 Reduced 0.55%
1,548,015 $8.68 Million
Q4 2021

Feb 11, 2022

BUY
$5.67 - $10.18 $228,756 - $410,712
40,345 Added 2.66%
1,556,601 $9.46 Million
Q3 2021

Nov 12, 2021

BUY
$9.17 - $14.24 $426,955 - $663,014
46,560 Added 3.17%
1,516,256 $14.8 Million
Q2 2021

Aug 13, 2021

BUY
$13.41 - $22.4 $10.8 Million - $18 Million
805,147 Added 121.16%
1,469,696 $21 Million
Q1 2021

May 12, 2021

BUY
$12.83 - $42.25 $8.53 Million - $28.1 Million
664,549 New
664,549 $15.8 Million

Others Institutions Holding IBRX

About ImmunityBio, Inc.


  • Ticker IBRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 400,304,000
  • Market Cap $1.05B
  • Description
  • ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...
More about IBRX
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.